Methodology

All entries for: BioMarin Pharmaceutical Inc.

February 26, 2026

BioMarin Pharmaceutical Inc.

Neutral Outlook

San Rafael, CA
1000-5000 employees

Thus, while it is unclear how the IRA will be implemented, it will likely have a significant impact on the pharmaceutical industry.

Disease Area: Cardiology, Chronic Disease, Multiple, Rare Diseases
Drug Type: Biologic, Small Molecule
Source
Source
July 11, 2025

BioMarin Pharmaceutical Inc.

Orphan Drug Designation

San Rafael, CA
1000-5000 employees

FDA orphan drug designation: treatment of short stature in Turner syndrome

Disease Area: Rare Diseases
Source
Source
Scroll to Top